Results 81 to 90 of about 5,604 (216)
Neurological complications of immune checkpoint inhibitors: what happens when you \u27take the brakes off\u27 the immune system. [PDF]
, 2018 Patients with advanced malignancies treated with immune checkpoint inhibitors are at increased risk for developing immune-related neurological complications.
Dalakas, Marinos
core +1 more source
Journal of Medical Case ReportsBackground Necrotizing myopathies and muscle necrosis can be caused by immune-mediated mechanisms, drugs, ischemia, and infections, and differential diagnosis may be challenging. Case presentation We describe a case of diabetic myonecrosis complicated by
Anne M. Kerola +6 more
doaj +1 more source
A case of seronegative immune-mediated necrotizing myopathy
Pifu-xingbing zhenliaoxue zazhiA case of statin-induced immune necrotizing myopathy with negative autoantibodies is reported. A 67-year-old female presented with generalized weakness and limb muscle soreness for 3 months, with worsening symptoms over the past month.
CUI Lin, XIE Bingxin, ZHANG Shifa
doaj +1 more source
Anti-Signal Recognition Particle Myopathy in a Geriatric Patient
European Journal of Case Reports in Internal Medicine, 2015 Anti-signal recognition particle (SRP) myopathy is a rare idiopathic inflammatory myositis that usually affects middle-age women, and is characterized by rapidly progressive proximal and symmetrical muscle weakness, elevated creatine kinase levels ...
Diana Marques Ferreira +4 more
doaj +1 more source
Thrombosis Journal, 2021 Background Immune-mediated necrotizing myopathy (IMNM) is characterized by proximal muscle weakness, elvated serum muscle enzyme levels, myopathic electromyography findings, and necrotic muscle fiber with few inflammatory cell infiltration in muscle ...
Jiali Li +5 more
doaj +1 more source
Signal Recognition Particle Myopathy With Cardiac Manifestations in Rheumatoid Arthritis
Annals of Internal Medicine: Clinical CasesImmune-mediated necrotizing myopathy is a rare inflammatory myopathy characterized by progressive muscle weakness and potentially severe systemic complications.
Priya Sunkara +3 more
doaj +1 more source
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report
Journal of Community Hospital Internal Medicine Perspectives, 2019 Statins are commonly used lipid lowering agents which play a pivotal role in reducing cardiovascular morbidity and mortality. Often well tolerated, these HMG-CoA reductase (HMGCR) inhibitors can sometimes cause severe muscle weakness and elevated ...
Sunita Upreti +2 more
doaj +1 more source
Publisher Copyright: © 2024 Sociedade Portuguesa de Reumatologia.Anti-HMGCR myopathy is an increasingly recognized immune-mediated necrotizing myopathy.
Barcelos, A. +3 more
core +1 more source
Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy [PDF]
The Journal of Rheumatology, 2018 Objective.A pathogenic role of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibodies has been proposed. Our objective was to assess efficacy of rituximab (RTX) in anti-HMGCR immune-mediated necrotizing myopathy.Methods.All patients who had been treated with RTX were retrospectively reviewed to assess features and outcome.Results ...
Landon-Cardinal, Océane +8 more
openaire +3 more sources
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series [PDF]
, 2021 Anji Xiong +9 more
openalex +1 more source